The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...

LP-284 targets DNA repair defects in cancers, showing promise in preclinical and early clinical trials across multiple cancer types. The FDA's orphan drug designation supports LP-284's development for ...

Doctors in Karachi have reported a growing number of musculoskeletal tumour cases, with specialists urging early diagnosis to prevent life-threatening complications.Speaking to The Express Tribune, ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...

Updated NCCN pediatric STS guidelines emphasize risk stratification, imaging, multimodal therapy, and clinical trial enrollment to improve outcomes. The National Comprehensive Cancer Network (NCCN) ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

A rare cancer Soft tissue sarcomas are rare—only about 13,500 cases are diagnosed in the United States each year. They arise from what are called mesenchymal cells, which form the connective tissues ...

The new NCCN Guidelines (R) for Pediatric Soft Tissue Sarcomas is now available for free at NCCN.org. They focus on a subtype called rhabdomyosarcoma (RMS) which is the most common type of soft tissue ...

About 3 in 5 people with soft palate cancer live for at least 5 years if they receive a diagnosis and treatment before the cancer spreads. Several factors can affect survival and life expectancy. Soft ...